Be informed...
Sentiment: Strong Buy
Listen and be informed!
Jefferies 2013 Global Healthcare Conference
Presentation date: Wednesday June 5, 2013
Presentation time: 8:30 a.m. E.T.
Sentiment: Strong Buy
Good update is on the way!
Sentiment: Strong Buy
Look forward to the conference!
Sentiment: Strong Buy
Look forward to the upcoming updates!
Sentiment: Strong Buy
Note Depression!
Broad potential with follow-on indications
Pain: MS Pain, DPN pain, many others
Mood/Behavior: Agitation in AD, autism, DEPRESSION
Movement Disorder: Dyskinesia, Chorea, spasticity
Sentiment: Strong Buy
Word is leaking out on how undervalued Avanir is based on it's clinical pipeline...
Sentiment: Strong Buy
Listen and be informed next week!
Sentiment: Strong Buy
A++++ investor slide deck....
Sentiment: Strong Buy
Like the potential....
Sentiment: Strong Buy
Avanir stakeholders have a lot to look forward to over the next 12 months; see the May 21 presentation on Avanir's website and be informed!
Sentiment: Strong Buy
to the update and investor presentation next week!
•Deutsche Bank 38th Annual Health Care Conference
•Presentation date: Wednesday May 29, 2013
•Presentation time: 12:00 p.m. P.T.
Sentiment: Strong Buy
Avanir now has Unrestricted tier 2 or tier 3 access in approx. 70% of covered lives in U.S.
Sentiment: Strong Buy
ALS, MS, Alzheimer’s, Stroke, Parkinson, TBI
18 million patients in the US with a Neurologic disease or injury.
Estimated 10% moderate-severe PBA:
PBA In Institutional Setting is 100,000 patients
PBA In Outpatient is 1,700,000
Sentiment: Strong Buy
Looking forward to the eventual Europe launch...
Sentiment: Strong Buy
We will have PH 2 Alzheimer's clinical trial results in about 10 months!
Sentiment: Strong Buy
Mannkind 40 million shares short and Avanir 20 million shares short! Mannkind shorts are now getting squeezed!
Sentiment: Strong Buy